Immune System and pregnancy: topics in both healthy women and rheumatic patients
Keywords:
pregnancy, immunological tolerance, rheumatic diseasesAbstract
Immune system's tolerance to semi-allogenic antigens during pregnancy is a particular case of response, very efficient in order to maintain the safety of binomius mother/foetus. In this review we emphasizes in those immunological and hormone mechanisms which are involved in tolerance to pregnancy. We also focus in patients with rheumatic autoimmune diseases, in which immunological tolerance mechanisms are broken as part of the pathogenesis of their diseases, whose pregnancies could ameliorate or worsened their conditions, and which recommendations would be usefully for these patients in order to have healthy pregnancy and babies.Downloads
References
Munoz-Suano A, Hamilton A. B, Betz A. G. Gimme shelter: the immune system during pregnancy. Immunol Rev. 241:20-38.
Guleria I, Sayegh M.H. Maternal Acceptance of the Fetus: True Human Tolerance. J. Immunol. 2007;178(6):3345-51.
Chen SJ, Liu YL, Sytwu HK. Immunologic regulation in pregnancy: from mechanism to therapeutic strategy for immunomodulation. Clinical and Developmental Immunology. 2011;2012. doi:10.1155/2012/258391
Burt TD. Fetal regulatory T cells and peripheral immune tolerance in utero: implications for development and disease. Am J Reprod Immunol . 2013;69(4):346-58.
Erlebacher A. Mechanisms of T cell tolerance towards the allogeneic fetus. Nat Rev Immunol .2001;(1):13, 23-33.
Kumpel B. M, Manoussaka M. S. Placental immunology and maternal alloimmune responses. V Sang. 2012;102,(1):2- 12.
Von Rango U. Fetal tolerance in human pregnancy--a crucial balance between acceptance and limitation of trophoblast invasion. Immunol Lett. 2008;115(1):21-32.
Doria A, Iaccarino L, Arienti S. Th2 immune deviation induced by pregnancy: the two faces of autoimmune rheumatic diseases. Reprod toxicol. 2006;22(2):234-41.
Bordon Y. Reproductive immunology: Hormonal support for regulatory T cells. Nat Rev Immunol. 2013;13:156
Ostensen M, Förger F, Villiger PM: Cytokines and pregnancy in rheumatic disease. Ann N Y Acad Sci. 2006;(6)1069:353-63.
VarshaJ .and Caroline G. Managing pregnancy in inflammatory rheumatological diseases. Arth Res Ther. 2011,13:206.
Ostensen M., Brucato A., Carp H., Chambers C., Radboud J. E., Doria A.,Gordon C. et.al. Pregnancy and reproduction in autoinmune rheumatic diseases. Rheumatol. 2011;50:657-64.
Gayed M., Gordon C. Pregnancy and rheumatic diseases .Rheumatol. 2009;46:1634-1640.
Cutolo M, Capellino S, Straub RH. Oestrogens in rheumatic diseases: friend or foe? Rheumatoloy. 2008; 47 Suppl 3:S2-5.
Buyon JP, Petri MA, Kim MY. The effect of combined estrogen and progesterone hormone replacement therapy on disease activity in systemic lupus erythematosus: a randomized trial. Ann Intern Med. 2005;142:953-62.
Petri M, Kim MY, Kalunian KC. Combined oral contraceptives in women with systemic lupus erythematosus. N Engl J Med. 2005;353:2550-8.
Ostensen M, Villiger PM. The remission of rheumatoid arthritis during pregnancy. Semin Immunopathol.2007;29:185-191.
De Man YA, Dolhain RJEM, van de Geijn FE, Willemsen SP, Hazes JMW. Disease activity of rheumatoid arthritis during pregnancy. Results from a nationwide prospective study. Arthritis Rheum. 2008;59:1241-8.
Doria A, Ghirardello A, Iaccarino L. Pregnancy, cytokines and disease activity in systemic lupus erythematosus. Arthritis Rheum. 2004;51:989-95.
Ostensen M. New insights into sexual functioning and fertility in rheumatic diseases. Best Pract Res Clin Rheumatol. 2004;18:219-32.
Su KY, Pisetsky DS. The role of extracellular DNA in autoimmunity in SLE. Scand J Immunol. 2009;70:175-83.
Kanda N, Tsuchida T, Tamaki K. Estrogen enhancement of anti-double-stranded DNA antibody and immunoglobulin G production in peripheral blood mononuclear cells from patients with systemic lupus erythematosus. Arthritis Rheum. 1999;42:328-37.
Bernier MO, Mikaeloff Y, Hudson M, Suissa S. Combined oral contraceptive use and the risk of systemic lupus erythematosus. Arthritis Rheum. 2009;61:476-81.
Ruiz-Irastorza G, Khamashta MA. Lupus and pregnancy: ten questions and some answers. Lupus. 2008;17:416-20.
Merino-Ibarra E., Delgado Beltrán C. Artritis reumatoide: ¿cómo usar los fármacos en el embarazo y la lactancia?_ Reumatol Clin. 2011;7(4):262-66.
De Man YA, Bakker-Jonges LE, Dufour-van den Goorbergh.. Women with rheumatoid arthritis negative for anti-CCP and rheumatoid factor are more likely to improve during pregnancy, whereas in autoantibody positive women autoantibody levels are not influenced by pregnancy. Ann Rheum Dis. 2010;69:420-3.
Yan Z, Lambert NC, Ostensen M, Adams KM, Guthrie KA, Nelson JL. Prospective study of fetal DNA in serum and disease activity during pregnancy in women withinflammatory arthritis. Arthritis Rheum. 2006;54:2069-73.
Rak JM, Maestroni L, Balandraud N. Transfer of the shared epitope through microchimerism in women with rheumatoid arthritis. Arthritis Rheum. 2009;60:73-80.
Forger F, Marcoli N, Gadola S, Moller B, Villiger PM, Ostensen M. Pregnancy induces numerical and functional changes of CD4+CD25high regulatory T cells in patients with rheumatoid arthritis. Ann Rheum Dis. 2008;67:984-90.
Clowse ME, Magder LS, Witter F, Petri M. Early risk factors for pregnancy loss in lupus. Obstet Gynecol. 2006;107:293-9.
Salmon J, Kim MY, Rana S. Angiogenic factor imbalance in pregnant SLE patients may explain increased risk for complications. Arthritis Rheum. 2009;60 :655.
Brucato A, Doria A, Frassi M. Pregnancy outcome in 100 women with autoimmune diseases and anti-Ro/SSA antibodies: a prospective controlled study. Lupus. 2002;11:203-11.
Sebire NJ, Backos M, El Gaddal S, Goldin RD, Regan L. Placental pathology, antiphospholipid antibodies, and pregnancy outcome in recurrent miscarriage patients. Obstet Gynecol. 2003;101:258-63.
Erkan D, Patel S, Nuzzo M. Management of the controversial aspects of the antiphospholipid syndrome pregnancies: a guide for clinicians and researchers. Rheumatology. 2008;47 Suppl 3:S23-7.
Rotar Z, Rozman B, de Groot PG. Sixth meeting of the European Forum on antiphospholipid antibodies. How to improve the understanding of the antiphospholipid syndrome? Lupus. 2009;18 :53-60.
Doria A, Bajocchi G, Tonon M, Salvarani C. Pre-pregnancy counselling of patients with vasculitis. Rheumatology. 2008;47 Suppl 3:S3-5.
Published
How to Cite
Issue
Section
License
Warning of rights of author
The authors that publish in this journal agree with the following terms:
The authors conserve the rights of author and concede to the journal the right of the first publication, fulfilling with the license Creative Commons Attribution License that allows to others share the work with recognition of the authorship of their articles, and the initial publication in this journal.
The authors can establish separately additional agreements for the no exclusive distribution of the version of the work published in the journal (for example, situate it in an institutional repository, in a personal blog or publish it partial or totally in a book), with a recognition of their initial publication in this journal.
To be able to send the manuscript or part of him passed three months of published, for his evaluation to other publishers, identifying it or not with the same title; whenever allusion is made to our journale and know it the new publisher.
The publishing committee of the Cuban Journal of Rheumatology authorizes to other publishers, to reproduce the articles published in our magazine, whenever it indicate the origin of the same.
The authors should send a document in Office Word application format through the electronic address of the magazine with a similar format to that we include next:
---------------------------------------------------------------------------------------------------------------------
Statement of authorship and cede of articles for the publication of the scientific work in the Cuban Journal of Rheumatology
Date:
Those who subscribe certify that are the authors of the work:
Of this form communicate the originality of our article clearing that the concepts and knowledges of other authors that have included in the text of the article, have been quoted properly in the bibliography.
We do proof besides that the article in question is original and has not been published, total neither partially, in another journal.
To be approved for his publication in the Cuban Journal of Rheumatology, do secession of the rights of publication to the same one through the method that realizes it usually.
In front of any catchword that exist by the article that send to evaluate, relieve of of the responsibility to the Cuban Journal of Rheumatology holding us responsible with all the difficulties that can berelated by any situation.
We include to continuation the name and the signature of all authors and collaborators of this article.
Name: Signature:
